Fusion CX IPO Launches for Subscription with 12% GMP—Time to Bid or Skip?

Fusion CX’s IPO, valued at Rs 702 crore, opened for subscription today, October 14, and will remain open until October 16. The offering includes a fresh issue of shares worth Rs 500 crore and an offer for sale (OFS) of 69.90 lakh shares amounting to Rs 202 crore. The price band is set between Rs 275–289 per share, necessitating a minimum investment of Rs 14,739 for retail investors aiming to acquire one lot of 51 shares. The share allocation is expected to be finalised on October 19, with a listing on the NSE and BSE scheduled for October 22, 2026.

In the grey market, Fusion CX’s IPO is currently trading at a premium of approximately 12% over the upper price band, suggesting healthy expectations for listing gains. The grey market premium (GMP) stands at Rs 33.5 per share, equating to around 11.6% above the top end of the price range. While the GMP serves as an informal gauge of market sentiment, investors should exercise caution as it does not definitively predict actual listing performance.

For Indian investors, Fusion CX’s IPO presents a compelling opportunity supported by its strong revenue growth and reasonable valuation compared to industry peers. With its strategic focus on reducing debt and investing in technological upgrades, the company aims to enhance operational efficiency and drive growth. Recommendations from analysts, including a “Subscribe – Long Term” rating from Anand Rathi, suggest that the IPO could positively impact retail portfolios, especially for those seeking exposure to customer experience and business process solutions.

Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova IPO team.)